Home/Recalls/FDA-D-0295-2026
FDA DrugsClass II

Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: S...

Published: January 28, 2026Recall ID: D-0295-2026Category: drugsCountry: US

Reason for Recall / Hazard

Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules

Product Description & Identification

Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07

Additional Source Details

FieldValue
CityPennington
StateNJ
Event id98227
Address 173 Route 31 N
Code infoLot # S2520304, S2520333, Exp 2/28/2027; S2540186, Exp 4/30/2027
Postal code08534-3601
Report date20260128
Product typeDrugs
Product quantity22,896 bottles
Reason for recallSubpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20251230
Initial firm notificationLetter
Center classification date20260122

Overview

  • Recalling FirmZydus Pharmaceuticals (USA) Inc
  • StatusOngoing
  • Risk LevelClass II
  • DistributionUS Nationwide.
Official Agency Alert